161 related articles for article (PubMed ID: 26586377)
1. Physiologically-Based Pharmacokinetic-Pharmacodynamic Modeling of 1α,25-Dihydroxyvitamin D3 in Mice.
Ramakrishnan V; Yang QJ; Quach HP; Cao Y; Chow EC; Mager DE; Pang KS
Drug Metab Dispos; 2016 Feb; 44(2):189-208. PubMed ID: 26586377
[TBL] [Abstract][Full Text] [Related]
2. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
3. Highlighting Vitamin D Receptor-Targeted Activities of 1
Yang QJ; Bukuroshi P; Quach HP; Chow ECY; Pang KS
Drug Metab Dispos; 2018 Jan; 46(1):75-87. PubMed ID: 29084783
[TBL] [Abstract][Full Text] [Related]
4. PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation.
Quach HP; Yang QJ; Chow EC; Mager DE; Hoi SY; Pang KS
Br J Pharmacol; 2015 Jul; 172(14):3611-26. PubMed ID: 25829051
[TBL] [Abstract][Full Text] [Related]
5. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
6. Noteworthy idiosyncrasies of 1α,25-dihydroxyvitamin D
Noh K; Yang QJ; Sekhon L; Quach HP; Chow ECY; Pang KS
Biopharm Drug Dispos; 2020 Mar; 41(3):126-148. PubMed ID: 32319119
[TBL] [Abstract][Full Text] [Related]
7. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
8. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
[TBL] [Abstract][Full Text] [Related]
9. Generation of 1,25-dihydroxyvitamin D
Nishikawa M; Yasuda K; Takamatsu M; Abe K; Nakagawa K; Tsugawa N; Hirota Y; Tanaka K; Yamashita S; Ikushiro S; Suda T; Okano T; Sakaki T
J Steroid Biochem Mol Biol; 2019 Jan; 185():71-79. PubMed ID: 30031146
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
11. Selection of High-Quality Spermatozoa May Be Promoted by Activated Vitamin D in the Woman.
Bøllehuus Hansen L; Rehfeld A; de Neergaard R; Nielsen JE; Iversen LH; Boisen IM; Mortensen LJ; Lanske B; Almstrup K; Carlsen E; Berg AH; Jørgensen N; Andersen AN; Juul A; Blomberg Jensen M
J Clin Endocrinol Metab; 2017 Mar; 102(3):950-961. PubMed ID: 27977320
[TBL] [Abstract][Full Text] [Related]
12. Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules.
Meyer MB; Benkusky NA; Lee SM; Yoon SH; Mannstadt M; Wein MN; Pike JW
J Biol Chem; 2022 Nov; 298(11):102559. PubMed ID: 36183832
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells.
Lechner D; Kállay E; Cross HS
Mol Cell Endocrinol; 2007 Jan; 263(1-2):55-64. PubMed ID: 17029768
[TBL] [Abstract][Full Text] [Related]
15. Genomic mechanisms controlling renal vitamin D metabolism.
Meyer MB; Pike JW
J Steroid Biochem Mol Biol; 2023 Apr; 228():106252. PubMed ID: 36657729
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
17. Mechanical loading and the synthesis of 1,25(OH)2D in primary human osteoblasts.
van der Meijden K; Bakker AD; van Essen HW; Heijboer AC; Schulten EA; Lips P; Bravenboer N
J Steroid Biochem Mol Biol; 2016 Feb; 156():32-9. PubMed ID: 26625962
[TBL] [Abstract][Full Text] [Related]
18. Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D
Kaufmann M; Martineau C; Arabian A; Traynor M; St-Arnaud R; Jones G
J Steroid Biochem Mol Biol; 2019 Apr; 188():23-28. PubMed ID: 30553931
[TBL] [Abstract][Full Text] [Related]
19. The vitamin D receptor in the proximal renal tubule is a key regulator of serum 1α,25-dihydroxyvitamin D₃.
Wang Y; Zhu J; DeLuca HF
Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E201-5. PubMed ID: 25425001
[TBL] [Abstract][Full Text] [Related]
20. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
